1,479
Views
5
CrossRef citations to date
0
Altmetric
Editorial

NanoTEST in a Nutshell

&

References

  • Aranda A, Sequedo L, Tolosa L, Quintas G, Burello E, Castell JV, Gombau L. 2013. Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: a quantitative method for oxidative stress assessment of nanoparticle-treated cells. Toxicol In Vitro 27:954–63
  • Burello E, Worth AP. 2011. Theoretical framework for predicting the oxidative stress potential of oxide nanoparticles. Nanotoxicology, DOI: 10.3109/17435390.2010. 502980 This was also reported on by the media http://www.rsc.org/chemistryworld/News/2010/July/26071001.asp
  • Burello E, Worth AP. 2015. A rule for designing safer nanomaterials: do not interfere with the cellular redox equilibrium. Nanotoxicology 9(S1):116–117
  • Cartwright L, Poulsen MS, Nielsen HM, Pojana G, Knudsen LE, Saunders M, Rytting E. 2011. In vitro placental model optimization for nanoparticle transport studies. Int J Nanomed 7:497–510
  • Correia Carreira S, Walker L, Paul K, Saunders M. 2015. The toxicity, transport and uptake of nanoparticles in the in vitro BeWo b30 placental cell barrier model used within NanoTEST. Nanotoxicology 9(S1):66–78
  • Cowie H, Magdolenova Z, Saunders M, Drlickova M, Correia Carreira S, Halamoda Kenzaoiu B, et al. 2015. Suitability of human and mammalian cells of different origin for the assessment of genotoxicity of metal and polymeric engineered nanoparticles. Nanotoxicology 9(S1):57–65
  • Dusinska M, Fjellsbø L, Magdolenova Z, Rinna A, Runden Pran E, Bartonova A, et al.; NanoTEST consortium. 2009. Testing strategies for the safety of nanoparticles used in medical application. Nanomedicine (editorial) 4:605–7
  • Dusinska M, Boland S, Saunders M, Juillerat-Jeanneret L, Tran L, Pojana G, et al. 2015. Towards an alternative testing strategy for nanomaterials used in nanomedicine: Lessons from NanoTEST. Nanotoxicology 9(S1):118–132
  • Guadagnini R, Halamoda Kenzaoui B, Cartwright L, Pojana G, Magdolenova Z, Bilanicova D, et al. 2015a. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology 9(S1):13–24
  • Guadagnini R, Moreau K, Hussain S, Marano F, Boland S. 2015b. Toxicity evaluation of engineered nanoparticles for medical applications using pulmonary epithelial cells. Nanotoxicology 9(S1):25–32
  • Halamoda Kenzaoui B, Vila MR, Miquel JM, Cengelli F, Juillerat-Jeanneret L. 2012a. Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells. Int J Nanomed 7:1275–86
  • Halamoda Kenzaoui B, Bernasconi C, Hofmann H, Juillerat-Jeanneret L. 2012b. Evaluation of uptake and transport of ultrasmallsuperparamagnetic iron oxide nanoparticles by human brain-derived endothelial cells. Nanomedicine 7:39–53
  • Halamoda Kenzaoui B, ChapuisBernasconi C, Guney-Ayra S, Juillerat-Jeanneret L. 2012c. Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain endothelial cells. Biochem J 441:813–21
  • Halamoda Kenzaoui B, Angeloni S, Overstolz T, Niedermann P, ChapuisBernasconi C, Liley M, Juillerat-Jeanneret L. 2013a. Transfer of ultrasmall iron oxide nanoparticles from human brain-derived endothelial cells to human glioblastoma cells. ACS Appl Mater Interfaces 5:3581–6
  • Halamoda Kenzaoui B, ChapuisBernasconi C, Juillerat-Jeanneret L. 2013b. Stress-reaction of kidney epithelial cells to inorganic solid-core nanoparticles. Cell Biol Toxicol 29:39–58
  • Harris G, Palosaari T, Magdolenova Z, Mennecozzi M, Gineste JM, Saavedra L, et al. 2015. Iron oxide nanoparticle toxicity testing using high throughput analysis and high content imaging. Nanotoxicology 9(S1):87–94
  • Juillerat-Jeanneret L, Dusinska M, Fjellsbø LM, Collins AR, Handy R, Riediker M. 2015. Biological impact assessment of nanomaterial used in nanomedicine. Introduction to the NanoTEST project. Nanotoxicology 9(S1):5–12
  • Kazimirova A, Magdolenova Z, Barancokova M, Staruchova M, Volkovova K, Dusinska M. 2012. Genotoxicity testing of PLGA-PEO nanoparticles in TK6 cells by the comet assay and the cytokinesis-block micronucleus assay. Mutat Res 748:42–7
  • Magdolenova Z, Bilaničová D, Pojana G, Fjellsbø LM, Hudecova A, Hasplova K, et al. 2012a. Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. J Environ Monit 14:455–64
  • Magdolenova Z, Lorenzo Y, Collins A, Dusinska M. 2012b. Can standard genotoxicity tests be applied to nanoparticles? J Toxicol Environ Health, Part A 75:800–6
  • Magdolenova Z, Drlickova M, Henjum K, Rundén-Pran E, Tulinska J, Bilanicova D, et al. 2015. Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles. Nanotoxicology 9(S1):44–56
  • Pilou M, Mavrofrydi O, Housiadas C, Eleftheriadis K, Papazafiri P. 2015. Computational modeling as part of alternative testing strategies in the respiratory and cardiovascular systems: inhaled nanoparticle dose modeling based on representative aerosol measurements and corresponding toxicological analysis. Nanotoxicology 9(S1):106–115
  • Poulsen MS, Mose T, Maroun LL, Mathiesen L, Knudsen LE, Rytting E. 2015. Kinetics of silica nanoparticles in the human placenta. Nanotoxicology 9(S1):79–86
  • Sebekova K, Dusinska M, Simon Klenovics K, Kollarova R, Boor P, Kebis A, et al. 2014. Comprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultra-small superparamagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats. Nanotoxicology 8:142–57
  • Tulinska J, Kazimirova A, Kuricova M, Barancokova M, Liskova A, Neubauerova E, et al. 2015. Immunotoxicity and genotoxicity testing of PLGA-PEO nanoparticles in human blood cell model. Nanotoxicology 9(S1):95–105
  • Volkovová K, Handy R, Staruchova M, Tulinska J, Kebis A, Pribojova J, et al. 2015. Health effects of selected nanoparticles in vivo: liver function and hepatotoxicity following intravenous injection of titanium dioxide and Na-oleate-coated iron oxide nanoparticles in rodents. Nanotoxicology 9(S1):33–43

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.